Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Health

Results: 1093-1104 of 8109

Business Wire logo

Silence Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Business Wire logo

BeOne Medicines Announces Third Quarter 2025 Financial Results and Business Updates

Business Wire logo

Samsung Bioepis Reaches Settlement Agreement for PYZCHIVA® (ustekinumab) in Europe

PR Newswire associated0

THE ADECCO GROUP Q3 2025 RESULTS

PR Newswire associated0

138th Canton Fair: Rising Demand for At-Home Healthcare Spurs Innovation in Smart Rehab and Wellness Tech

Business Wire logo

10X Health and REVIV Global Announce Strategic Partnership with M42 to Launch 10XREVIV in Abu Dhabi

PR Newswire associated0

The World's First Gene-Editing Therapy Targeting APOC3 for Hyperlipidemia

PR Newswire associated0

Jazz Pharmaceuticals Announces Third Quarter 2025 Financial Results and Updates 2025 Financial Guidance

Sobi to present New One-Year Data on pegcetacoplan's efficacy in C3G and primary IC-MPGN and new outcome data on NASP at ASN Kidney Week

Imricor’s NorthStar® Mapping System

First in Human Ischemic VT Ablation Successfully Performed in iCMR

"With a similar safety profile, OPN can be a feasible and faster alternative to IVL." Dr. M. Bossard, Senior Physician at Luzerner Kantonsspital, Switzerland

SIS Medical AG Welcomes the Results of the VICTORY Trial Demonstrating Non-inferiority of OPN NC to Intravascular Lithotrispy (IVL) for Lesion Preparation and Stent Expansion in Severely Calcified Lesions

Santen Receives UK Approval for Ryjunea® (low-dose atropine 0.1 mg/ml) to Slow Progression of Childhood Myopia

  • Prev Page
  • 1
  • 2
  • …
  • 91
  • 92
  • 93
  • …
  • 675
  • 676
  • Next Page

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us